Page last updated: 2024-12-09

2-(3-Chloro-2-fluorophenyl)-2,3-dihydroisothiazol-3-one

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

2-(3-Chloro-2-fluorophenyl)-2,3-dihydroisothiazol-3-one, also known as **chlorofluorophenylimidazole**, is a heterocyclic compound with a distinct chemical structure.

**Importance in Research:**

This compound is primarily studied for its potential **antimicrobial and antifungal properties**. It has shown promising activity against a range of microorganisms, including:

* **Bacteria:** It has been shown to inhibit the growth of both Gram-positive and Gram-negative bacteria, making it a potential candidate for the development of new antibiotics.
* **Fungi:** It has also demonstrated antifungal activity against a variety of fungal species, including those responsible for infections in humans and plants.

**Mechanism of Action:**

The exact mechanism of action of chlorofluorophenylimidazole is still being investigated, but it is believed to act by disrupting the normal function of microbial cell membranes and/or interfering with essential enzyme systems.

**Research Applications:**

* **Antimicrobial Drug Development:** The research on chlorofluorophenylimidazole is focusing on its potential as a lead compound for the development of new antibiotics and antifungals.
* **Agricultural Applications:** Its antifungal properties could be valuable in protecting crops from fungal diseases.
* **Industrial Applications:** It may also find applications in other industries, such as the preservation of materials and the control of microbial growth in industrial processes.

**Key Points to Remember:**

* Chlorofluorophenylimidazole is a promising compound with potential applications in various fields.
* More research is needed to fully understand its mechanism of action and optimize its properties for specific applications.
* Its potential toxicity and environmental impact also need to be carefully assessed before it can be widely used.

**Note:** This information is for general knowledge and should not be considered medical or scientific advice.

Cross-References

ID SourceID
PubMed CID615185
CHEMBL ID489102
CHEBI ID194685
SCHEMBL ID13886603

Synonyms (16)

Synonym
MAYBRIDGE1_005025 ,
2-(3-chloro-2-fluorophenyl)isothiazol-3(2h)-one
bdbm50247616
HMS555M09
2-(3-chloro-2-fluorophenyl)-1,2-thiazol-3-one
CHEMBL489102 ,
cct004466
2-(3-chloro-2-fluorophenyl)-2,3-dihydroisothiazol-3-one
2-(3-chloro-2-luorophenyl)-1,2-thiazol-3-one
CHEBI:194685
2-(3-chloro-2-fluorophenyl)-3(2h)-isothiazolone
FLVXYAGCEOJNQC-UHFFFAOYSA-N
SCHEMBL13886603
cyto5g8
220862-89-5
PD195564
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organofluorine compoundAn organofluorine compound is a compound containing at least one carbon-fluorine bond.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Indoleamine 2,3-dioxygenase 1Homo sapiens (human)IC50 (µMol)71.93330.05373.075710.0000AID1184068; AID1184069; AID1184073
Histone acetyltransferase KAT2BHomo sapiens (human)IC50 (µMol)5.40005.00006.01678.5000AID347655
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (55)

Processvia Protein(s)Taxonomy
regulation of activated T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell tolerance inductionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of chronic inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of type 2 immune responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
inflammatory responseIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
female pregnancyIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan catabolic process to kynurenineIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
response to lipopolysaccharideIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of interleukin-10 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of interleukin-12 productionIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
multicellular organismal response to stressIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
kynurenic acid biosynthetic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
swimming behaviorIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell proliferationIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
positive regulation of T cell apoptotic processIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
'de novo' NAD biosynthetic process from tryptophanIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
negative regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription from RNA polymerase II promoter by glucoseHistone acetyltransferase KAT2BHomo sapiens (human)
gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA repairHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
protein acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
heart developmentHistone acetyltransferase KAT2BHomo sapiens (human)
memoryHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of cell population proliferationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of protein ADP-ribosylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of neuron projection developmentHistone acetyltransferase KAT2BHomo sapiens (human)
N-terminal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
internal peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
peptidyl-lysine acetylationHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to insulin stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to oxidative stressHistone acetyltransferase KAT2BHomo sapiens (human)
vasodilationHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of RNA splicingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of gluconeogenesisHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of fatty acid biosynthetic processHistone acetyltransferase KAT2BHomo sapiens (human)
transcription initiation-coupled chromatin remodelingHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of glycolytic processHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of DNA-templated transcriptionHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of embryonic developmentHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of centriole replicationHistone acetyltransferase KAT2BHomo sapiens (human)
rhythmic processHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell divisionHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of cell cycleHistone acetyltransferase KAT2BHomo sapiens (human)
limb developmentHistone acetyltransferase KAT2BHomo sapiens (human)
cellular response to parathyroid hormone stimulusHistone acetyltransferase KAT2BHomo sapiens (human)
regulation of tubulin deacetylationHistone acetyltransferase KAT2BHomo sapiens (human)
positive regulation of attachment of mitotic spindle microtubules to kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
negative regulation of rRNA processingHistone acetyltransferase KAT2BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (22)

Processvia Protein(s)Taxonomy
electron transfer activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
heme bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
indoleamine 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
metal ion bindingIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
tryptophan 2,3-dioxygenase activityIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
RNA polymerase II transcription regulatory region sequence-specific DNA bindingHistone acetyltransferase KAT2BHomo sapiens (human)
chromatin bindingHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coregulator activityHistone acetyltransferase KAT2BHomo sapiens (human)
transcription coactivator activityHistone acetyltransferase KAT2BHomo sapiens (human)
diamine N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
lysine N-acetyltransferase activity, acting on acetyl phosphate as donorHistone acetyltransferase KAT2BHomo sapiens (human)
cyclin-dependent protein serine/threonine kinase inhibitor activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein bindingHistone acetyltransferase KAT2BHomo sapiens (human)
acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
protein kinase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone acetyltransferase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone deacetylase bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3K9 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
peptide-lysine-N-acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
DNA-binding transcription factor bindingHistone acetyltransferase KAT2BHomo sapiens (human)
histone H3 acetyltransferase activityHistone acetyltransferase KAT2BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (15)

Processvia Protein(s)Taxonomy
cytosolIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
smooth muscle contractile fiberIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
stereocilium bundleIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
cytoplasmIndoleamine 2,3-dioxygenase 1Homo sapiens (human)
SAGA complexHistone acetyltransferase KAT2BHomo sapiens (human)
kinetochoreHistone acetyltransferase KAT2BHomo sapiens (human)
nucleusHistone acetyltransferase KAT2BHomo sapiens (human)
nucleoplasmHistone acetyltransferase KAT2BHomo sapiens (human)
centrosomeHistone acetyltransferase KAT2BHomo sapiens (human)
cytosolHistone acetyltransferase KAT2BHomo sapiens (human)
A bandHistone acetyltransferase KAT2BHomo sapiens (human)
I bandHistone acetyltransferase KAT2BHomo sapiens (human)
actomyosinHistone acetyltransferase KAT2BHomo sapiens (human)
mitotic spindleHistone acetyltransferase KAT2BHomo sapiens (human)
ATAC complexHistone acetyltransferase KAT2BHomo sapiens (human)
protein-containing complexHistone acetyltransferase KAT2BHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (12)

Assay IDTitleYearJournalArticle
AID1184068Inhibition of IDO1 (unknown origin) using L-tryptophan substrate incubated for 60 mins by HPLC2014European journal of medicinal chemistry, Sep-12, Volume: 84Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID1184073Inhibition of IDO1 (unknown origin) using L-tryptophan substrate incubated for 60 mins in presence of 5 mM GSH by HPLC2014European journal of medicinal chemistry, Sep-12, Volume: 84Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID1184069Inhibition of IDO1 (unknown origin) using L-tryptophan substrate incubated for 60 mins in presence of 0.01% Triton-X by HPLC2014European journal of medicinal chemistry, Sep-12, Volume: 84Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID1184071Inhibition of mouse TDO expressed in mouse P815B cells using L-tryptophan substrate incubated for 24 hrs by HPLC based cellular assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID1184072Cytotoxicity against mouse P815B cells after 24 hrs by MTS/PMS assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID1184070Inhibition of mouse IDO1 expressed in mouse P815B cells using L-tryptophan substrate incubated for 18 hrs by HPLC based cellular assay2014European journal of medicinal chemistry, Sep-12, Volume: 84Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID1184075Inhibition of IDO1 (unknown origin) at highest soluble concentration using L-tryptophan substrate incubated for 60 mins by HPLC2014European journal of medicinal chemistry, Sep-12, Volume: 84Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID1184074Solubility of the compound in pH 6.5 phosphate buffer containing 5% DMSO2014European journal of medicinal chemistry, Sep-12, Volume: 84Detailed analysis and follow-up studies of a high-throughput screening for indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors.
AID347655Inhibition of GST-fused recombinant HAT PCAF expressed in Escherichia coli by filter assay2009Bioorganic & medicinal chemistry, Jan-15, Volume: 17, Issue:2
Synthesis of isothiazol-3-one derivatives as inhibitors of histone acetyltransferases (HATs).
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).2014Journal of biomolecular screening, Jul, Volume: 19, Issue:6
A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum.
AID1794808Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL).
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (20.00)29.6817
2010's3 (60.00)24.3611
2020's1 (20.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.13

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.13 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.13)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]